Canadian Drug Expert Committee Grants Positive Recommendation for Reimbursement of Galafold Biotech Investing
Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025 Pharmaceutical Investing
Faron Pharmaceuticals: FDA grants Fast Track Designation to Faron for Traumakine® Pharmaceutical Investing
Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations Biotech Investing
BioStem Technologies Announces the Engagement of Investment Banking Firm Young America Capital for $15 Million Offering. Biotech Investing
